i-Expand

💍𝐀 𝐧𝐞𝐰 𝐡𝐞𝐚𝐥𝐭𝐡 𝐭𝐞𝐜𝐡 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐢𝐬 𝐛𝐨𝐫𝐧? Oura has just announced the acquisition of data company Sparta Science to expand its B2B offerings. This is their third purchase in two years. Why is this deal special ❓Oura may have put the ring on a #platform strategy. Let's unpack this. 🟣 𝐏𝐋𝐀𝐓𝐅𝐎𝐑𝐌 𝐁𝐔𝐒𝐈𝐍𝐄𝐒𝐒 𝐌𝐎𝐃𝐄𝐋𝐒 Healthcare platforms combine various services and vendors on one virtual platform to offer users a holistic solution. 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬 𝐚𝐧𝐝 𝐭𝐡𝐞𝐢𝐫 𝐄𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐧𝐞𝐰 𝐦𝐚𝐫𝐤𝐞𝐭𝐬. Platforms challenge traditional views on competition or #partnerships. Who your direct competitor is will not matter so much as which ecosystem you belong to. The race to partner/ buy is on. 🟣 𝐇𝐎𝐖 𝐀 𝐏𝐋𝐀𝐓𝐅𝐎𝐑𝐌 𝐈𝐒 𝐁𝐎𝐑𝐍 Platform ecosystems are not galaxies born overnight. There is no Big Bang but rather an organic process. ✺Suppose the company is born to be a platform. In that case, it usually starts very narrowly, with one primary sponsor connected to individual players in a two-sided model connected by the platform (i.e. suppliers and customers). e.g. Amazon sold books for many years. ✺Suppose the company was born as a pipeline #business (selling a product like Oura ring). In that case, the platform play becomes a second act once the number of users (suppliers and customers) and interactions rise. How does that happen? 𝐏𝐇𝐀𝐒𝐄 𝐈 The focus is on collaboration. Oura started in 2015 as a monitoring solution to improve sleep and performance. Little by little, they built a closed environment for their members to collaborate. Oura for Business launched in 2022, providing personalized insights for individuals and customized tools for leaders. Last year, Oura acquired the digital identification platform Proxy. 𝐏𝐇𝐀𝐒𝐄 𝐈𝐈 The orchestrator provides other services to increase stickiness and loyalty. Last month, Oura agreed to acquire Veri, which offers personalized metabolic #health programs. 𝐏𝐇𝐀𝐒𝐄 𝐈𝐈𝐈 The platform #business architecture comes to life. Sparta's Trinsic platform will allow Oura's enterprise partners to combine the ring's data with "𝘵𝘩𝘪𝘳𝘥-𝘱𝘢𝘳𝘵𝘺 𝘥𝘢𝘵𝘢 𝘴𝘰𝘶𝘳𝘤𝘦𝘴" 𝘢𝘯𝘥 "𝘦𝘯𝘢𝘣𝘭𝘦 𝘤𝘶𝘴𝘵𝘰𝘮𝘪𝘻𝘢𝘣𝘭𝘦 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘪𝘯𝘵𝘦𝘨𝘳𝘢𝘵𝘦 𝘸𝘪𝘵𝘩 𝘦𝘹𝘪𝘴𝘵𝘪𝘯𝘨 𝘴𝘺𝘴𝘵𝘦𝘮𝘴 (#Emr) or create workflows. This way Oura's customers can build niche applications "such as optimizing sailors' schedules for maximum rest, recovery, and early detection of illness." >Oura becomes the orchestrator. Huma has showed us that not only #bigtech can become a #healthtech #data platform. Will ŌURA be next❓ Vince,Dmitry PS: Wonder how #dataplatforms make money? That's our panel topic at the eHealth Workforce Development Conference 2024. Dr. JOIN US (link below). 🟣 i-Expand ➟ #commercialization #biotechology #digitalhealth #entrepreneurship #uae

See you next week at eHealth Workforce Development Conference 2024?

𝐆𝐨𝐨𝐝 𝐦𝐨𝐫𝐧𝐢𝐧𝐠 #𝐝𝐞𝐞𝐩𝐭𝐞𝐜𝐡! The European Innovation Council (EIC) has just approved €1.4 billion to support European deep tech research and high-potential #startups next year. 🟣The EIC Work Programme 2025 is built around three main #funding schemes: 1️⃣ EIC Pathfinder - €262 million for multi-disciplinary research teams to undertake visionary early-stage technology research and development with the potential to lead to technology breakthroughs (grants up to €4 million). 2️⃣ EIC Transition - €98 million to turn research results into innovation opportunities, following up on results generated by EIC Pathfinder, European Research Council Proof of Concept and Horizon Europe Pillar 2 (societal challenges) collaborative projects (grants up to €2.5 million). 3️⃣ EIC Accelerator - €634 million for start-ups and SMEs to develop, commercialise and scale up innovations with the potential to create new markets or disrupt existing ones (grants below €2.5 million, investments from €500 000 to €10 million). In addition, the EIC Strategic Technologies for Europe Platform (STEP) Scale-up scheme - €300 million - will provide additional equity funding to promising companies driving innovation in critical areas (SMEs, start-ups, spin-offs and small mid-caps) to help them secure larger private co-investment for further scaling their businesses (investments from €10 to €30 million). 🟣 Not sure how to get started❓ All potential applicants can join the EIC information days that will take place on 5th (general one) and 6th (EIC Accelerator Challenges) of November 2024. #womentechEU AcrossLimits Imperial Venture Mentoring Service (IVMS) 🟣 i-Expand ➟ #commercialization #biotechology #digitalhealth #entrepreneurship #healthtech #venturecapital #eic #entrepreneurship

KSA welcomes #healthtech innovation propelled by the Global Health Exhibition - ملتقى الصحة العالمي

🎗️ 𝐂𝐚𝐧𝐜𝐞𝐫 𝐢𝐬 𝐠𝐞𝐭𝐭𝐢𝐧𝐠 𝐲𝐨𝐮𝐧𝐠𝐞𝐫. *Doctor: You have Stage 3 Breast Cancer. *Patient: But my last mammogram was clear, I don’t have family history and I am still young. What did I do wrong? *Doctor: We’re seeing more aggressive tumours in younger people. We don't know why. Back in 2018 I thought my fate was sealed. Luckily, I am still around to tell the story of how cancer is getting younger. 🟣 𝐂𝐀𝐍𝐂𝐄𝐑 & 𝐀𝐆𝐄 For decades, the risk of developing cancer increased with age. However, a worrying trend has emerged: More young people are being diagnosed with advanced-stage cancers. In contrast, rates of cancer diagnosis and death are dropping in older people. Researchers are baffled. 🟣 𝐘𝐎𝐔𝐍𝐆, 𝐅𝐀𝐒𝐓 𝐀𝐍𝐃 𝐅𝐔𝐑𝐈𝐎𝐔𝐒 A Nature study made a huge splash: Millennials are developing EO cancer at epidemic rates. Globally, EO cancer incidence rose by 80% from 1990 to 2019, with the fastest increase in the 15-39 age group. Cancer is already the primary cause of mortality in the 15–49 age group. Breast, digestive, and respiratory cancers are particularly lethal. 8 of 14 rising cancers impact the digestive system, with colorectal cancer now most common in those <50. Why are those rogue cells turning so aggressive❓ 🟣 𝐄𝐎 𝐂𝐀𝐍𝐂𝐄𝐑: 𝐄𝐗𝐏𝐎𝐒𝐄𝐃 Researchers are still defining the causal factors of this epidemic. Evidence points to two culprits: 𝐄𝐗𝐏𝐎𝐒𝐎𝐌𝐄- 𝐒𝐨𝐦𝐞𝐭𝐡𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐚𝐢𝐫 Environmental factors, including chemicals, diet, stressors, and lifestyle, impact biology and health. Collectively, they make up the exposome. Beyond diet and lifestyle, pollutants play a key role. Industrialization has increased exposure to harmful substances from prenatal stages, that may even affect embryonic development. Assessing exposures is challenging due to a lack of longitudinal studies. The #epigenome can provide historical footprint of exposures from early gestation, with DNA methylation serving as a a great proxy. 𝐒𝐔𝐒𝐂𝐄𝐏𝐓𝐈𝐁𝐈𝐋𝐈𝐓𝐘- 𝐒𝐨𝐦𝐞𝐭𝐡𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐮𝐭 Genetic, polygenic, or epigenetic predisposition affects how an individual responds to environmental exposures. The gut microbiome also impacts the immune system. 🟣 𝐋𝐄𝐒𝐒 𝐑𝐈𝐁𝐁𝐎𝐍𝐒, 𝐌𝐎𝐑𝐄 𝐑𝐄𝐒𝐄𝐀𝐑𝐂𝐇 Understanding why this is happening is a priority. ✺Do young tumours evolve like those in older patients? ✺Does age affect drug response? Treatment algorithms based on senior samples lead to one-size-fits-all drugs. 🟣 𝐂𝐀𝐍𝐂𝐄𝐑 𝐈𝐒 𝐏𝐄𝐑𝐒𝐎𝐍𝐀𝐋 A cancer diagnosis in young individuals is especially challenging. While hair loss may be temporary, side effects such as infertility, depression, pain can be lasting. #Cancer is expensive too. What public #health measures do we take❓ How about the right to be forgotten by #insurers❓ How can #healthtech provide personalized treatments❓ Let's make cancer month history. 🟣 i-Expand ➟ #commercialization #digitalhealth #uae

This week, all the #healthtech paths lead to Riyadh🔺 The end destination is the Global Health Exhibition - ملتقى الصحة العالمي. The who is who of healthcare will be there. Where should you go, who should you meet❓ Like in all big events, a planner is essential. Below are a few highlights. 🟣 𝐌𝐀𝐈𝐍 𝐒𝐓𝐎𝐏𝐒 ✺ Leaders Summit- Join industry pioneers, policymakers, government, strategists, and scientists and get inspired. ✺ Medical Excellence Forum- Explore innovations across the different clinical workflows. ✺ Patient Safety Forum- A spotlight on enhancing diagnostic accuracy and improving outcomes. ✺ Digital Health Forum- Learn how AI and advanced analytics are revolutionizing healthcare. ✺ Investor's Forum- Discover cutting-edge healthcare investment opportunities. A few personal checkpoints: Vision Next-Gen Competition (see below), Seha Virtual Hospital and Aramco. 🟣 𝐑𝐎𝐔𝐓𝐄 𝐏𝐋𝐀𝐍𝐍𝐄𝐑 (mine) 🏁 𝐃𝐀𝐘 2 𝐕𝐢𝐬𝐢𝐨𝐧 𝐍𝐞𝐱𝐭𝐆𝐞𝐧 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧- During 3 days, 22 judges will crown the "Innovator of the Year," showcasing solutions tackling the most critical health challenges. It is a privilege and great responsability to be part of the semi-final jury together with Roberto, Dr. Mohammed Alhamali, Dr Sufana Almashadi, Dr Adil Monshi, Eng Abdullah Alshamrani and more. 𝐖𝐇𝐄𝐑𝐄 & 𝐖𝐇𝐄𝐍 Investor Forum. Hall 3C 22nd October (4:30 - 6:30 PM) 𝐖𝐇𝐘 This competition is a unique platform for showcasing groundbreaking ideas and connecting with key stakeholders, including 1K+ investors. 😎 30+ startups will compete in 3 phases for 1 winner spot. Join us and let’s find out who! 🏁 𝐃𝐀𝐘 3 Panel: 𝐁𝐚𝐥𝐚𝐧𝐜𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧,𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐄𝐦𝐞𝐫𝐠𝐞𝐧𝐜𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐄𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐖𝐇𝐄𝐑𝐄 & 𝐖𝐇𝐄𝐍 Leaders Summit (Main stage) 23rd October (13:30 – 14:00) 𝐖𝐇𝐘 Digital #platforms and their associated ecosystems are the new markets. Already entrenched in other verticals, we are now witnessing the birth of the Healthcare Ecosystems. Healthcare ecosystems represent a new business order with new rules of engagement. ✺ What are they, why do they matter, and what role should you play? ✺ What are the implications at policy, provisioning, and competition level? ✺ Is #health ready? Are you? You are in for a treat with Kristina, Dr. Mostafa Shaheen Hadi Alenazy. Wonderful Rachel McArthur will set the rhythm. Let's find out together what it means for you. What are your tips❓ (side events too) 💃 🟣 𝐒𝐀𝐔𝐃𝐈 𝐕𝐈𝐒𝐈𝐎𝐍 2030 Eventually, all the roads converge into one main stop: Saudi Vision 2030. Healthcare will play a pivotal role. GHE will show us how. If you are in town, get on the #GHE24 platform! ☀️Thanks to Felicia, Summaya for top organization and Mark Mohamad for the linkup. 🟣 i-Expand ➟ #commercialization #digitalhealth #entrepreneurship #uae

Sharjah was one of the first places I visited when I moved to the #UAE. My first Ramadan majlis, hosted by HH Sheikha Bodour, was also there.🌙 That is where I found out about Sheraa. Ever since, I have wanted to partner with them. Planets have finally aligned under Expand North Star: We officially launched our collaboration this week 💃 🟣 As an expert in residence, my focus will be helping Sheraa's #startups translate their products into businesses. As a taster, we delivered the first workshop on Agritech commercialization. As a welcome, we had the privilege to join the Sharjah delegation, headed by Sara Al Nuaimi, and greet the startups exhibiting there. Thanks for your trust Najla Al-Midfa, Abeer AlAmeeri, Nader Aboulhosn, Lamya AlSerkal, Tarun Krishna, and the rest of the team. It is a privilege. 🟣 𝐀𝐁𝐎𝐔𝐓 𝐒𝐇𝐄𝐑𝐀𝐀 The Sharjah Entrepreneurship Center (Sheraa) works with entrepreneurs to build, launch, and scale startups that make a significant impact in their communities. Do you want to find out more❓ At the end of every year, Sheraa hosts the annual Sharjah Entrepreneurship Festival, which brings together over 5,000 entrepreneurs, investors, creators, industry leaders and the youth for two days. Cannot wait till then❓ Connect with Tarun for more information. 🟣 This launch is our 33rd accelerator partnership. 33 is a strong number associated with the power to make things happen. Sheraa's mission is to make entrepreneurship happen, too. I am delighted to embark on this journey with you. Happy weekend everybody! 🟣 i-Expand ➟ #commercialization #biotechology #digitalhealth #entrepreneurship #uae #SEF2024 #gitex

In Dubai tomorrow at North Star? Here is some food for thought on commercialization :)

It is finally out! Excited to announce I am part of the ⭐Women TechEU Internal Advisory Board ⭐ 🟣 The Women TechEU is an EU-funded project supporting women leading deep tech start-up companies in Europe and Associated Countries. Taking over from the work carried out in the past by the European Commission, the Women TechEU project is currently being led by a consortium of partners from 8 countries across Europe. 🟣 The advisory board is made up of 4 professionals from diverse countries and industries. The role of the board is to give the consortium guidance and an outside perspective on how the project is progressing. Working with the formidable Angele GIULIANO and learning from the other board members will be a privilege. Sasha Bezuhanova Claudia Blomgren-Hansen Romana Krizova Thanks for the trust, and I look forward to working with all the consortium members to push boundaries further. (Not only in Deep tech but also in female #entrepreneurship). 𝐌𝐨𝐫𝐞 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬?  Please scroll below or go to our website (link below). ▄▀▄▀▄▀ 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐖𝐨𝐦𝐞𝐧 𝐓𝐞𝐜𝐡𝐄𝐔? Women TechEU is a 2-year EU-funded project supporting women leading deep tech #startup companies from Europe and Associated Countries. The project will launch four calls for applications over the span of 2 years, which, following a rigorous evaluation process, will result in a total of 160 beneficiaries. 𝐖𝐡𝐨 𝐜𝐚𝐧 𝐚𝐩𝐩𝐥𝐲? Women TechEU targets early-stage deep tech startups founded or co-founded by women holding a top management position (CEO, CTO, or equivalent). Women should hold at least 25% of the shares in the company at the time of submission. The company must have been registered and established in an EU Member State or a Horizon Europe Associated Country for at least six months and a maximum of eight years from the time of submission. Furthermore they must be at a stage before reaching a high fidelity Minimum Viable Product 1 (not more than TRL6) as well as having raised less than 1M€ in equity. 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐞𝐥𝐢𝐠𝐢𝐛𝐥𝐞 𝐢𝐟 𝐲𝐨𝐮 𝐚𝐫𝐞 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐭𝐡𝐞 𝐄𝐔? Yes, if you are from Albania, Armenia, Bosnia and Herzegovina, the Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Tunisia, Türkiye, Ukraine, the UK, or Morocco. #WomenTechEU  #WomenInTech #WomenEntrepreneurs #deeptech 🟣 i-Expand ➟ #commercialization #biotechology #healthtech #digitalhealth #UAE

𝘉𝘪𝘳𝘥𝘴 𝘰𝘧 𝘵𝘩𝘦 𝘴𝘢𝘮𝘦 𝘧𝘦𝘢𝘵𝘩𝘦𝘳 "𝘤𝘭𝘪𝘤𝘬" 𝘵𝘰𝘨𝘦𝘵𝘩𝘦𝘳. After publishing the Annual Algorithm Report, research shows LinkedIn performance metrics are declining-for original creators 👀. Does the new LI algorithm prioritize AI-generated posts over original content❓ 🟣𝐖𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐞𝐭𝐫𝐢𝐜𝐬 𝐬𝐡𝐨𝐰 Users report decreased views, follower growth, and engagement. Key metrics show that impressions, follower growth, and engagement have decreased significantly. Sponsored content and AI-generated posts now dominate feeds. Reportedly, most major content creators are experiencing reduced reach. In contrast, AI-generated or sponsored views have increased dramatically. Fun fact: LinkedIn seems to be favouring specific content topics around AI (don’t we all?) ✺ Is that a case of machine trumping human❓ ✺ Do we need to up the game in terms of original content quality❓ ✺ Will it matter ❓ 🟣The article prompted me to check. I don’t fall into the major creator category, but I am a frequent one. There is a gap in views compared to last year, which is paradoxical as engagement is even higher. Most worryingly, my wall used to be full with my favourite peers' content. Now suggestions to follow other people's posts (sponsored I guess) populate my feed. ✺ What is your experience❓ Philippe João Jon Vijay Aliya 🟣 𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 LinkedIn is a formidable partner for B2B businesses. That extra view can put business owners and startups on the radar of the next partner, customer, investor. Don't let the wrong algo get in the way :) Let's keep it ORIGINAL. Happy Friday, everybody! PS: Thanks to Swipe insight for feature. 🟣 i-Expand ➟ #commercialization #biotechology #digitalhealth #entrepreneurship #uae